Treatment
-
Can CRISPR Deliver?A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
-
The Puzzle of Pancreatic CancerPancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
-
The Coronavirus and Cancer CareCancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
-
Medicare Coverage for Next-Generation Sequencing TestsMultigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
For Prostate Biopsy, It’s Best to Combine Old and New MethodsUsing an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.
by Kate Yandell
-
New Drugs for an Elusive Cancer TargetMedical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
-
Clinical Trials: An African American Survivor’s ExperienceMelvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
-
Turning Up the Heat on CancerResearchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.
by Kendall K. Morgan
-
Forward Look
Early Chemotherapy Dose Reductions May Affect Breast Cancer OutcomesNew study explores impact of lowering dose due to side effects.
by Jane Langille
-
Forward Look
Targeted Treatments for TotsNew law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
